Eating on Time: Why When You Eat Matters

Dr. Jonathan Moustakis

Co-founder and CTO of Lume Health

Dr. Emily N. C. Manoogian

Chronobiologist and Clinical Researcher at The Salk Institute for Biological Studies

2 min read

Peptides for Wellness & Health Optimization

Peptides are short chains of amino acids (the same fundamental building blocks that make up proteins) but they function in the body in a unique and highly targeted way. Rather than acting as structural components like many larger proteins, peptides typically serve as biological signaling molecules, helping cells communicate and coordinate complex physiological processes.

They play essential roles in regulating metabolism, hormone release, immune responses, inflammation, tissue repair, appetite, sleep, and many other functions. Examples of naturally occurring peptides include insulin, glucagon, growth hormone–releasing peptides, and numerous immune signaling molecules.

Because of their size and structure, peptides occupy a distinct space between traditional small-molecule drugs and larger biologic therapies. This gives them several unique characteristics:

High specificity

Peptides often bind very precisely to receptors, allowing them to influence particular biological pathways with relatively targeted effects.

Powerful physiological impact

Even small changes in peptide signaling can lead to meaningful changes in metabolism, recovery, or hormonal rhythms.

Shorter biological half-lives

Many peptides are rapidly broken down in the body, which can reduce long-term accumulation but may require careful dosing strategies.

Growing therapeutic interest

Advances in biotechnology have made it easier to design and synthesize peptides, leading to increasing exploration of their potential uses in medicine and longevity science.

For these reasons, peptides are often discussed as a category of their own. They represent a class of bioactive molecules that can directly influence regulatory systems within the body.

However, this biological potency also means that peptides are not risk-free.

Peptides are not risk-free. Before considering their use, it is essential to carefully weigh potential benefits against possible risks: side effects, unknown long-term outcomes, dosing challenges, and product purity. Decisions should be based on credible evidence and ideally made in consultation with a qualified healthcare professional.

The table below summarizes commonly discussed peptides, their mechanisms of action, and the current state of evidence.

A Multiple large RCTs
B Strong RCT; optimization off-label
C Small or surrogate-endpoint human trials
D Limited human evidence
E No persuasive human evidence; primarily preclinical
Regulatory note: WADA status reflects the 2026 Prohibited List. For educational purposes only. Always consult a licensed physician.

Incretin & Metabolic Peptides

Peptide (Brand Names)EvidenceIndicationRegulatory Status
SemaglutideWegovy, Ozempic, RybelsusAObesity (BMI ≥30 or ≥27 + comorbidity); T2DM; CV risk reductionFDA-approved 2021 (obesity). EMA Jan 2022. Rx only.WADA: Not prohibited
TirzepatideZepbound, MounjaroAObesity; T2DM; obstructive sleep apnea in adults with obesityFDA-approved 2022 (T2DM), 2023 (obesity), 2024 (OSA). Rx only.WADA: Not prohibited
LiraglutideSaxenda, VictozaAObesity (BMI ≥30 or ≥27 + comorbidity); T2DMFDA-approved (Rx). Saxenda label current 2025.WADA: Not prohibited
ExenatideByetta, Bydureon ERBT2DM (not primarily indicated for obesity/wellness)FDA-approved (Rx). Byetta label current 2025.WADA: Not prohibited
PramlintideSymlinBT2DM and T1DM insulin adjunct; studied for obesity as lifestyle adjunctFDA-approved (Rx) for diabetes adjunct. Obesity use off-label.WADA: Not prohibited

Growth Hormone (GH) Axis Peptides

Peptide (Brand Names)EvidenceIndicationRegulatory Status
TesamorelinEgrifta WRBHIV lipodystrophy (excess abdominal fat). NOT indicated for weight loss managementFDA-approved (Rx) for HIV lipodystrophy ONLY.WADA: Prohibited (S2)
SermorelinGeref (discontinued)CHistorically: pediatric GH deficiency. Now compounded off-label for anti-aging / body compositionUS product withdrawn. Compounded only. Not FDA-approved.WADA: Prohibited (S2)
CJC-1295CJC-1295 w/ DAC; MOD GRF 1-29CInvestigational: GH/IGF-1 axis enhancement, body composition, anti-agingNot FDA-approved. Higher-risk bulk substance for compounding.WADA: Prohibited (S2)
IpamorelinIpamorelinCInvestigational: GH secretagogue. Phase II RCT for postoperative ileus showed NO significant benefitNot FDA-approved. Bulk substance with potential significant safety risk.WADA: Prohibited (S2)
GHRP-2Pralmorelin (Japan: diagnostic)CClinical GH stimulation/diagnostic use (Japan approved). Wellness use not clinically validatedNot FDA-approved. Japan approval for diagnostic use only.WADA: Prohibited (S2)
GHRP-6GHRP-6DInvestigational: GH secretagogue. No robust wellness outcomes RCT baseNot FDA-approved. FDA compounding risk flagged.WADA: Prohibited (S2)

Melanocortin Peptides

Peptide (Brand Names)EvidenceIndicationRegulatory Status
AfamelanotideScenesse, Melanotan IBErythropoietic protoporphyria (EPP). NOT a tanning drugFDA-approved for EPP indication only (2019).WADA: Not prohibited
Melanotan IIMT-IIEMarketed for tanning/libido. NOT approved anywhere. Serious adverse event case reportsNot FDA-approved. FDA flags significant safety concerns.WADA: Not prohibited
PT-141 (Bremelanotide)VyleesiAHSDD in premenopausal women. NOT for postmenopausal women, men, or performance enhancementFDA-approved June 2019 (NDA 210557). Premenopausal HSDD only.WADA: Not prohibited

Neurobehavioral Peptides

Peptide (Brand Names)EvidenceIndicationRegulatory Status
OxytocinPitocin, intranasal (off-label)CFDA-approved: obstetric indications. Off-label/research: autism social outcomes, anxiety, bondingFDA-approved for obstetric indications only. Intranasal wellness is off-label/research.WADA: Not prohibited
DesmopressinNocdurna, DDAVPBNocturia; central diabetes insipidus; nocturnal enuresis. NOT a wellness agentFDA-approved (Rx). Boxed warning for hyponatremia.WADA: Not prohibited
DSIPEmideltide, Delta Sleep-Inducing PeptideDInvestigational: sleep induction, insomnia. Evidence weak and limitedNot FDA-approved. Higher-risk compounding bulk substance.WADA: Not prohibited
SelankSelankCAnxiety, cognitive enhancement (Russia/Ukraine approved). Research compound in Western marketsApproved in Russia. NOT approved in US, EU, or UK.WADA: Not prohibited
SemaxSemaxDCognitive enhancement, neuroprotection (Russia/Ukraine approved). Not approved in Western marketsApproved in Russia. NOT approved in US, EU, or UK.WADA: Not prohibited

Endocrine Peptides

Peptide (Brand Names)EvidenceIndicationRegulatory Status
Kisspeptin-10Kp-10CInvestigational: reproductive endocrinology, LH/FSH stimulation, emerging sexual function researchNot FDA-approved. FDA compounding risk flagged.WADA: Not prohibited

Repair & Regenerative Peptides

Peptide (Brand Names)EvidenceIndicationRegulatory Status
BPC-157Body Protection Compound-157, PL-14736EInvestigational: GI mucosal healing, tendon/ligament repair, wound healing. Human evidence sparseNot FDA-approved. Bulk substance with potential significant safety risks.WADA: Not prohibited
TB-500TB-500 (LKKTETQ fragment)EInvestigational: tissue repair, wound healing. NOT full-length Thymosin β4Not FDA-approved. Bulk substance with potential significant safety risks.WADA: Not prohibited
LL-37LL-37, Human cathelicidinCInvestigational: wound healing (venous leg ulcers), innate immune modulationNot FDA-approved. FDA compounding risk flagged.WADA: Not prohibited

Immune, Longevity & Other Peptides

Peptide (Brand Names)EvidenceIndicationRegulatory Status
Thymosin Alpha-1Zadaxin, ThymalfasinCHepatitis B/C, cancer adjunct, immune deficiency (approved China, Italy, 35+ countries). Not FDA-approvedApproved in China, Italy (Zadaxin), 35+ countries. NOT FDA-approved.WADA: Not prohibited
GHK-CuCopper tripeptide, copper peptideDCosmetic/dermatologic: skin aging, wound healing (topical). Injectable claims NOT validatedNot FDA-approved as a drug. FDA compounding risk flagged for injectable forms.WADA: Not prohibited
EpithalonEpitalon, Epithalone, AEDGEInvestigational: longevity, circadian rhythm restoration, telomere biology. No robust human clinical evidenceNot approved anywhere. Research use only. FDA compounding risk flagged.WADA: Not prohibited
MOTS-cMOTS-cEInvestigational: metabolic disease, aging, exercise performance. No human RCTsNot approved. Research compound. FDA compounding risk flagged.WADA: Not prohibited

In recent years, the science of time-restricted eating (TRE) has gained momentum. But beneath the headlines lies something deeper: your metabolism doesn’t just respond to what you eat; it runs on a schedule.

In this piece, co-authored by Dr. Emily Manoogian, a researcher at the Salk Institute and leading expert on circadian rhythms and time-restricted eating, and Dr. Jonathan Moustakis, medical doctor and co-founder of Lume Health, we explore how aligning mealtimes with our biological clocks can enhance metabolic health, sleep, and long-term well-being.

As Dr. Manoogian’s research has shown, the timing of our behaviors, like eating, can dramatically influence our health outcomes. In this article, we turn the science into simple, actionable tools-because when you eat matters just as much as what you eat.

Your Metabolism Has a Clock

There is a central clock in our brains that takes in information from our environment, like light, and determines the timing of our behavior. We also have trillions of peripheral clocks throughout our bodies. If a cell has DNA, it has a clock. These peripheral clocks are influenced by our behavior and our central clock, but they are also very sensitive to food timing, syncing our metabolism to predictable windows of eating and fasting.

Insulin sensitivity, glucose tolerance, gut motility, and even hunger hormones like ghrelin all follow circadian rhythms. In the morning, after you have been awake for a bit and gotten lots of bright light, your body is primed to process food efficiently. At night, these systems slow down, preparing for a nightly fast when you sleep. Eating late throws a wrench into that process.

That is why shift workers, night eaters, or people with erratic meal times often have higher rates of obesity, type 2 diabetes, and metabolic disease, even when calorie intake is the same.

What Is Time-Restricted Eating?

Time-restricted eating limits all calorie intake to a consistent window each day, typically 8 to 10 hours, and involves fasting the rest of the time. What sets TRE apart from other fasting strategies is its emphasis on circadian alignment, the idea that when you eat should match when your body expects food.

What the Science Shows

Controlled studies show that circadian-aligned time-restricted eating (TRE) can lead to wide-ranging improvements in metabolic and overall health:

Insulin Sensitivity and Blood Sugar:
TRE improves glycaemic control even in the absence of weight loss. In a 2024 randomized controlled trial, participants with impaired glucose metabolism saw significant improvements in 24-hour glucose profiles when following a personalized 8-10 hour eating window, compared to those eating over 12 hours or more.

Blood Pressure and Cholesterol:
TRE has been shown to reduce systolic blood pressure and LDL cholesterol. A review noted consistent improvements in cardiometabolic markers across studies, especially when TRE is aligned with the body’s active phase.

Weight Loss:
A 2022 trial found that participants practicing TRE lost a significant amount of weight over 14 weeks compared to controls eating across a wider time window.

Sleep Quality and Quality of Life:
A study found that a TRE pattern improved self-reported sleep quality and health-related quality of life (HRQoL), likely by reinforcing circadian rhythm amplitude and limiting late-night eating, which can interfere with sleep and hormone regulation.

Perhaps most striking, many of these benefits appear independent of calorie restriction or specific dietary composition, highlighting that timing itself is therapeutic.

TRE vs. Skipping Breakfast

It is common to hear people say, “I already fast, I skip breakfast.” But this pattern, eating from noon to 8 PM, is typically misaligned with circadian biology. Delaying your first meal shifts food intake into the evening, when the body is least insulin-sensitive and least prepared to digest and metabolize nutrients efficiently.

A 2023 review concluded that when the first meal was consumed before noon, TRE results in superior outcomes for blood sugar control, weight loss, and cardiometabolic health compared to late TRE patterns that omit breakfast.

The point is to support our body’s rhythms and eat when you are active, not to skip meals when our bodies are expecting it.

Actionable Takeaways

  1. Eat during the day, not at night

    Aim to finish your last meal at least 3 to 4 hours before bed. Insulin sensitivity drops in the evening, so late meals are more likely to spike blood sugar and interfere with overnight recovery.

  2. Keep a consistent eating window
    Choose a 10-hour window that starts in the morning (1-4 hours after you wake up), for example, 9 AM to 7 PM, and stick to it daily. Regularity strengthens our body’s circadian rhythms. If you eat late one day, don’t eat later the next morning. Just get back on your normal schedule.

  3. Focus on rhythm, not restriction
    TRE is not about cutting calories or obsessing over macros. It is about restoring a natural rhythm to your eating. Let your biology do the heavy lifting.

Dr. Jonathan Moustakis

Co-founder and CTO of Lume Health

Dr. Emily N. C. Manoogian

Chronobiologist and Clinical Researcher at The Salk Institute for Biological Studies